Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Metamorphoses of Lyme disease spirochetes: phenomenon of Borrelia persisters.

Rudenko N, Golovchenko M, Kybicova K, Vancova M.

Parasit Vectors. 2019 May 16;12(1):237. doi: 10.1186/s13071-019-3495-7. Review.

2.

Antimicrobial action of calprotectin that does not involve metal withholding.

Besold AN, Culbertson EM, Nam L, Hobbs RP, Boyko A, Maxwell CN, Chazin WJ, Marques AR, Culotta VC.

Metallomics. 2018 Dec 12;10(12):1728-1742. doi: 10.1039/c8mt00133b.

PMID:
30206620
3.

Improvement of common variable immunodeficiency using embryonic stem cell therapy in a patient with lyme disease: a clinical case report.

Horowitz R, Freeman PR.

Clin Case Rep. 2018 May 2;6(6):1166-1171. doi: 10.1002/ccr3.1556. eCollection 2018 Jun.

4.

Antimicrobial Activity of Bee Venom and Melittin against Borrelia burgdorferi.

Socarras KM, Theophilus PAS, Torres JP, Gupta K, Sapi E.

Antibiotics (Basel). 2017 Nov 29;6(4). pii: E31. doi: 10.3390/antibiotics6040031.

5.

Sleeper cells: the stringent response and persistence in the Borreliella (Borrelia) burgdorferi enzootic cycle.

Cabello FC, Godfrey HP, Bugrysheva JV, Newman SA.

Environ Microbiol. 2017 Oct;19(10):3846-3862. doi: 10.1111/1462-2920.13897. Epub 2017 Sep 11. Review.

6.

Pleomorphism and Viability of the Lyme Disease Pathogen Borrelia burgdorferi Exposed to Physiological Stress Conditions: A Correlative Cryo-Fluorescence and Cryo-Scanning Electron Microscopy Study.

Vancová M, Rudenko N, Vaněček J, Golovchenko M, Strnad M, Rego ROM, Tichá L, Grubhoffer L, Nebesářová J.

Front Microbiol. 2017 Apr 11;8:596. doi: 10.3389/fmicb.2017.00596. eCollection 2017.

7.

Borrelia burgdorferi Keeps Moving and Carries on: A Review of Borrelial Dissemination and Invasion.

Hyde JA.

Front Immunol. 2017 Feb 21;8:114. doi: 10.3389/fimmu.2017.00114. eCollection 2017. Review.

8.

Effect of RpoN, RpoS and LuxS Pathways on the Biofilm Formation and Antibiotic Sensitivity of Borrelia Burgdorferi.

Sapi E, Theophilus PA, Pham TV, Burugu D, Luecke DF.

Eur J Microbiol Immunol (Bp). 2016 Nov 3;6(4):272-286. eCollection 2016 Dec 1.

9.

Cooperation of Doxycycline with Phytochemicals and Micronutrients Against Active and Persistent Forms of Borrelia sp.

Goc A, Niedzwiecki A, Rath M.

Int J Biol Sci. 2016 Jul 22;12(9):1093-103. doi: 10.7150/ijbs.16060. eCollection 2016.

10.

The anti-borreliae efficacy of phytochemicals and micronutrients: an update.

Goc A, Rath M.

Ther Adv Infect Dis. 2016 Jun;3(3-4):75-82. doi: 10.1177/2049936116655502. Epub 2016 Jul 4. Review.

11.

Evidence of In Vivo Existence of Borrelia Biofilm in Borrelial Lymphocytomas.

Sapi E, Balasubramanian K, Poruri A, Maghsoudlou JS, Socarras KM, Timmaraju AV, Filush KR, Gupta K, Shaikh S, Theophilus PA, Luecke DF, MacDonald A, Zelger B.

Eur J Microbiol Immunol (Bp). 2016 Feb 9;6(1):9-24. doi: 10.1556/1886.2015.00049. eCollection 2016 Mar.

12.

Effectiveness of Stevia Rebaudiana Whole Leaf Extract Against the Various Morphological Forms of Borrelia Burgdorferi in Vitro.

Theophilus PA, Victoria MJ, Socarras KM, Filush KR, Gupta K, Luecke DF, Sapi E.

Eur J Microbiol Immunol (Bp). 2015 Nov 12;5(4):268-80. doi: 10.1556/1886.2015.00031. eCollection 2015 Dec.

13.

Application of Nanotrap technology for high sensitivity measurement of urinary outer surface protein A carboxyl-terminus domain in early stage Lyme borreliosis.

Magni R, Espina BH, Shah K, Lepene B, Mayuga C, Douglas TA, Espina V, Rucker S, Dunlap R, Petricoin EF, Kilavos MF, Poretz DM, Irwin GR, Shor SM, Liotta LA, Luchini A.

J Transl Med. 2015 Nov 4;13:346. doi: 10.1186/s12967-015-0701-z.

14.

In vitro evaluation of antibacterial activity of phytochemicals and micronutrients against Borrelia burgdorferi and Borrelia garinii.

Goc A, Niedzwiecki A, Rath M.

J Appl Microbiol. 2015 Dec;119(6):1561-72. doi: 10.1111/jam.12970.

15.

The Borrelia burgdorferi RelA/SpoT Homolog and Stringent Response Regulate Survival in the Tick Vector and Global Gene Expression during Starvation.

Drecktrah D, Lybecker M, Popitsch N, Rescheneder P, Hall LS, Samuels DS.

PLoS Pathog. 2015 Sep 15;11(9):e1005160. doi: 10.1371/journal.ppat.1005160. eCollection 2015 Sep. Erratum in: PLoS Pathog. 2015 Oct;11(10):e1005242.

16.

Lyme Borreliosis: Is there a preexisting (natural) variation in antimicrobial susceptibility among Borrelia burgdorferi strains?

Hodzic E.

Bosn J Basic Med Sci. 2015 Jul 8;15(3):1-13. doi: 10.17305/bjbms.2015.594. Review.

17.

Within-host competition between Borrelia afzelii ospC strains in wild hosts as revealed by massively parallel amplicon sequencing.

Strandh M, Råberg L.

Philos Trans R Soc Lond B Biol Sci. 2015 Aug 19;370(1675). pii: 20140293. doi: 10.1098/rstb.2014.0293.

18.

Drug combinations against Borrelia burgdorferi persisters in vitro: eradication achieved by using daptomycin, cefoperazone and doxycycline.

Feng J, Auwaerter PG, Zhang Y.

PLoS One. 2015 Mar 25;10(3):e0117207. doi: 10.1371/journal.pone.0117207. eCollection 2015.

19.

Morphological and biochemical features of Borrelia burgdorferi pleomorphic forms.

Meriläinen L, Herranen A, Schwarzbach A, Gilbert L.

Microbiology. 2015 Mar;161(Pt 3):516-27. doi: 10.1099/mic.0.000027. Epub 2015 Jan 6.

20.

Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease.

Cameron DJ, Johnson LB, Maloney EL.

Expert Rev Anti Infect Ther. 2014 Sep;12(9):1103-35. doi: 10.1586/14787210.2014.940900. Epub 2014 Jul 30. Review.

Supplemental Content

Support Center